In reply: An article by Stockigt1 and follow-up correspondence from Mallows raised concerns about the limitations of approved product information (PI).
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- Therapeutic Goods Administration, Canberra, ACT.
Correspondence: david.graham@health.gov.au
- 1. Stockigt JR. Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications. Med J Aust 2007; 186: 76-79. <MJA full text>
Online responses are no longer available. Please refer to our instructions for authors page for more information.